Potassium-competitive acid blocker use is associated with a lower risk of renal function deterioration compared to proton pump inhibitor use

被引:0
|
作者
Jang, Minyoung [1 ]
Jeong, Seoin [1 ]
Kim, Jeongyun [1 ]
Gu, Juyeon [1 ]
Kim, Minji [1 ]
Jeon, Junseok [1 ]
Jang, Hye Ryoun [1 ]
Lee, Jung Eun [1 ]
Huh, Wooseong [1 ]
Lee, Kyungho [1 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea
关键词
D O I
10.1093/ndt/gfae069.155
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
2338
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Potassium-competitive acid blockers-are they the next generation of proton pump inhibitors?
    Prashanth Rawla
    Tagore Sunkara
    Andrew Ofosu
    Vinaya Gaduputi
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2018, (07) : 63 - 68
  • [32] Structural Basis for Binding of Potassium-Competitive Acid Blockers to the Gastric Proton Pump
    Tanaka, Saki
    Morita, Mikio
    Yamagishi, Tatsuya
    Madapally, Hridya Valia
    Hayashida, Kenichi
    Khandelia, Himanshu
    Gerle, Christoph
    Shigematsu, Hideki
    Oshima, Atsunori
    Abe, Kazuhiro
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (11) : 7843 - 7853
  • [33] The Ameliorating Effect of Switching to Vonoprazan: A Novel Potassium-Competitive Acid Blocker in Patients with Proton Pump Inhibitor Refractory Non-Erosive Reflux Disease
    Abe, Yasuaki
    Koike, Tomoyuki
    Saito, Masahiro
    Okata, Tomoki
    Nakagawa, Kenichiro
    Hatta, Waku
    Asanuma, Kiyotaka
    Uno, Kaname
    Asano, Naoki
    Imatani, Akira
    Masamune, Atsushi
    DIGESTION, 2021, 102 (03) : 480 - 488
  • [34] COST-UTILITY ANALYSIS OF POTASSIUM-COMPETITIVE ACID BLOCKER-BASED THERAPEUTIC STRATEGY FOR GASTROESOPHAGEAL REFLUX DISEASE COMPARED WITH PROTON-PUMP INHIBITOR-BASED STRATEGY
    Higuchi, Kazuhide
    Uda, Akihito
    Deguchi, Hisato
    Ueda, Kazuo
    Watanabe, Yasuhito
    Iwasaki, Kosuke
    Igarashi, Ataru
    GASTROENTEROLOGY, 2018, 154 (06) : S455 - S456
  • [35] EFFICACIES OF POTASSIUM-COMPETITIVE ACID BLOCKER-BASED HIGHDOSE DUAL THERAPY, POTASSIUM-COMPETITIVE ACID BLOCKER-BASED TRIPLE THERAPY AND PROTON PUMP INHIBITOR-BASED REVERSE HYBRID THERAPY IN THE FIRST-LINE ANTI-H. PYLORI TREATMENT
    Hsu, Ping-I
    Chen, Chien-Lin
    Shih, Chih-An
    Chen, Kuan-Yang
    Lee, Chia-Long
    Chuah, Seng-Kee
    Tsay, Feng-Woei Tsay
    Wang, Jiunn-Wei
    Wu, Deng-Chyang
    GASTROENTEROLOGY, 2023, 164 (06) : S375 - S375
  • [36] The Efficacy and Safety of Vonoprazan, a Potassium-Competitive Acid Blocker, for the Treatment of Proton-Pump Inhibitor-Resistant Gastroesophageal Reflux Disease: A Systematic Review and MetaAnalysis
    Lesmana, Elvira
    Simadibrata, Daniel Martin
    Fass, Ronnie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S364 - S364
  • [37] POTASSIUM-COMPETITIVE ACID BLOCKER VERSUS PROTON PUMP INHIBITOR AS FIRST-LINE TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Yamade, Mihoko
    Suzuki, Takahiro
    Kagami, Takuma
    Ichikawa, Hitomi
    Uotani, Takahiro
    Shirai, Naohito
    Hamaya, Yasushi
    Iwaizumi, Moriya
    Osawa, Satoshi
    Sugimoto, Ken
    Furuta, Takahisa
    GASTROENTEROLOGY, 2017, 152 (05) : S151 - S152
  • [38] DOUBLE-BLIND RANDOMIZED TRIAL OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN VS. THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN US AND EUROPEAN PATIENTS WITH EROSIVE ESOPHAGITIS
    Laine, Loren
    Devault, Kenneth R.
    Katz, Philip O.
    Mitev, Stefan
    Lowe, John
    Hunt, Barbara
    Spechler, Stuart J.
    GASTROENTEROLOGY, 2022, 162 (07) : S214 - S214
  • [39] Letter: a potassium-competitive acid blocker vs a proton pump inhibitor for healing endoscopic submucosal dissection-induced artificial ulcers after treatment of gastric neoplasms
    Ban, H.
    Sugimoto, M.
    Otsuka, T.
    Murata, M.
    Nakata, T.
    Hasegawa, H.
    Fukuda, M.
    Inatomi, O.
    Bamba, S.
    Kushima, R.
    Andoh, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (05) : 564 - 565
  • [40] Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
    Carmelo Scarpignato
    Richard H. Hunt
    Current Gastroenterology Reports, 2024, 26 (11) : 273 - 293